LFCR Q1 2019 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$256M

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$125M+1.1% YoY

Gross Profit

$16M13.1% margin

Operating Income

-$447,000-0.4% margin

Net Income

$190,0000.2% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

-11.6%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$12M

Stock-Based Comp.

$728,000

Balance Sheet

Total Assets

$403M

Total Liabilities

$150M

Stockholders' Equity

$253M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$125M	$123M	+1.1%
Gross Profit	$16M	$19M	-15.3%
Operating Income	-$447,000	$3M	-117.7%
Net Income	$190,000	$2M	-91.1%